Picture of Sun Pharmaceutical Industries logo

SUNPHARMA — Sun Pharmaceutical Industries News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

India's top drugmaker Sun Pharma beats profit view on specialty drugs demand

May 22 (Reuters) - India's top drugmaker by revenue Sun Pharmaceutical Industries SUN.NS beat quarterly profit estimates on Friday helped by demand for company's high-margin specialty drugs used to treat complex conditions.

The Mumbai-based firm's consolidated net profit stood at 27.14 billion rupees ($283 million) for the quarter ended March 31, from 21.50 billion rupees last year.

That was above analysts' average estimate of 27.12 billion rupees, according to data compiled by LSEG.

($1 = 95.9125 Indian rupees)

 (Reporting by Rishika Sadam and Kashish Tandon)

 ((Rishika.Sadam@thomsonreuters.com;))

Recent news on Sun Pharmaceutical Industries

See all news